Concepedia
Journal of Thrombosis and Haemostasis · 2019 · 11 citations · 13 references
Open access
MedicineHematologyInternal MedicineHemostasisPlatelet DisordersThromboembolic DiseaseThrombosisThrombosis PreventionThrombotic DisordersVenous ThromboembolismPathophysiology Of PruritusPruritus PathogenesisThrombocyte Disorders
13
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer et al. · New England Journal of Medicine · 2015 · 872 citations
Medicine, Hematology, Pharmacology +14
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård et al. · Journal of Clinical Oncology · 2011 · 834 citations · Full text
Medicine, Hematology, Oncology +17
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Elisa Rumi, Daniela Pietra, Virginia Valeria Ferretti et al. · Blood · 2013 · 585 citations · Full text
Medicine, Genetics, Hematology +13
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli et al. · Blood · 2007 · 444 citations
Life Sciences, Genetics, Molecular Genetics +10
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients
Robyn M. Scherber, Amylou C. Dueck, Peter Johansson et al. · Blood · 2011 · 336 citations · Full text
Medicine, Hematology, Oncology +10